Table 2 Logistics regression. SIRPB1 expression associated with clinical pathological characteristics
Characteristics | Total (N) | Odds Ratio (OR) in SIRPB1 expression | P |
|---|---|---|---|
WHO grade (WHO-IV vs. WHO-II&III) | 613 | 6.37 (4.14–10.08) |  < 0.001 |
IDH status (Wildtype vs. Mutant) | 661 | 4.45 (3.16–6.33) |  < 0.001 |
1p/19q co-deletion (codel vs. non-codel) | 664 | 0.27 (0.18–0.40) |  < 0.001 |
Primary therapy outcome (CR vs. PD&SD&PR) | 444 | 0.57 (0.37–0.87) | 0.009 |
EGFR status (Mutant vs. Wildtype) | 656 | 1.69 (1.03–2.81) | 0.039 |
PIK3CA status (Mutant vs. Wildtype) | 656 | 1.04 (0.58–1.87) | 0.899 |